Innovative Strategies for the Discovery of New Drugs Against Androgenetic Alopecia

The article discusses the need for innovative strategies in drug discovery for androgenetic alopecia (AGA), the most common form of hair loss, which has significant psychological and social impacts. Current treatments like minoxidil and finasteride have limited efficacy and side effects, prompting the exploration of new therapies targeting androgen receptors, prostaglandin analogs, and WNT signaling. The authors emphasize the importance of developing better in vitro and in vivo models, such as those using induced pluripotent stem cells (iPSCs), to accelerate research. They also highlight the potential of improved drug delivery systems in the near term and the promise of treatments that address AGA's underlying pathophysiology for long-term benefits.